SM
AXDX

Selkirk Management’s Accelerate Diagnostics AXDX Stock Holding History

Selkirk Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,199
Closed -$1.53M – 14
2021
Q3 		$1.53M Hold
26,199
– – 0.62% 16
2021
Q2 		$2.11M Sell
26,199
-2,682
-9% -$213K 0.77% 16
2021
Q1 		$2.4M Sell
28,881
-6,000
-17% -$609K 0.71% 21
2020
Q4 		$2.64M Hold
34,881
– – 0.86% 21
2020
Q3 		$3.72M Hold
34,881
– – 1.18% 19
2020
Q2 		$5.29M Hold
34,881
– – 2.27% 18
2020
Q1 		$2.91M Hold
34,881
– – 1.64% 19
2019
Q4 		$5.89M Hold
34,881
– – 2.95% 17
2019
Q3 		$6.48M Hold
34,881
– – 3.66% 14
2019
Q2 		$7.98M Hold
34,881
– – 4.29% 12
2019
Q1 		$7.33M Hold
34,881
– – 4.16% 13
2018
Q4 		$4.01M Buy
34,881
+736
+2% +$109K 2.71% 16
2018
Q3 		$7.84M Hold
34,145
– – 3.99% 12
2018
Q2 		$7.61M Sell
34,145
-2,010
-6% -$450K 3.92% 13
2018
Q1 		$8.26M Hold
36,155
– – 4.24% 10
2017
Q4 		$9.47M Sell
36,155
-7,845
-18% -$1.84M 5.06% 8
2017
Q3 		$9.88M Buy
44,000
+4,000
+10% +$982K 5.4% 7
2017
Q2 		$10.9M Hold
40,000
– – 6.2% 6
2017
Q1 		$9.68M Buy
40,000
+4,400
+12% +$1.01M 5.48% 8
2016
Q4 		$7.39M Buy
35,600
+6,460
+22% +$1.53M 4.69% 9
2016
Q3 		$7.94M Hold
29,140
– – 4.88% 9
2016
Q2 		$4.19M Hold
29,140
– – 2.53% 16
2016
Q1 		$4.19M Sell
29,140
-3,112
-10% -$439K 2.62% 16
2015
Q4 		$6.93M Buy
32,252
+7,750
+32% +$1.41M 4.08% 11
2015
Q3 		$3.96M Buy
24,502
+3,702
+18% +$801K 2.46% 15
2015
Q2 		$5.37M Hold
20,800
– – 2.94% 14
2015
Q1 		$4.68M Buy
20,800
+4,230
+26% +$884K 2.6% 14
2014
Q4 		$3.18M Hold
16,570
– – 1.9% 16
2014
Q3 		$3.56M Buy
+16,570
New +$3.22M 2.24% 17

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Selkirk Management's AXDX Position: Q4 2021 in Review

Selkirk Management sold out of Accelerate Diagnostics (AXDX) in Q4 2021, closing a stake of 26,199 shares — an estimated $1.53M sold.

Selkirk Management first reported a position in AXDX in Q3 2014 and held it in 29 quarters. The position peaked at $10.9M in Q2 2017. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2021.

  • Selkirk Management reported no remaining Accelerate Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Selkirk Management sold 26,199 Accelerate Diagnostics shares in Q4 2021, an estimated $1.53M.
  • Selkirk Management first reported a position in Accelerate Diagnostics in Q3 2014 and held it in 29 quarters.
  • Selkirk Management's Accelerate Diagnostics position peaked at $10.9M in Q2 2017.
  • 107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2021.

Based on Selkirk Management's 13F filing for Q4 2021, filed 14 Feb 2022.